Transparency Calls in FDA Drug Approvals Stir Tensions ...Middle East

Devdiscourse - Opinion
Transparency Calls in FDA Drug Approvals Stir Tensions
The Institute for Clinical and Economic Review (ICER) is urging the U.S. Food and Drug Administration (FDA) to increase transparency in its accelerated approval of certain drugs. In a recent report, ICER highlighted issues with the FDA's use of surrogate endpoints, which predict clinical benefit without direct measurement, fast-tracking drug approvals for serious conditions lacking treatments.

Hence then, the article about transparency calls in fda drug approvals stir tensions was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Transparency Calls in FDA Drug Approvals Stir Tensions )

Apple Storegoogle play

Last updated :

Also on site :